(a) The executive commissioner by rule shall require the treating physician of a patient admitted to a treatment facility licensed by the department under Chapter 464 or a person designated by the physician to provide to the patient in the patient’s primary language, if possible, information relating to prescription medications ordered by the physician.
(b) At a minimum, the required information must:
(1) identify the major types of prescription medications; and
(2) specify for each major type:
(A) the conditions the medications are commonly used to treat;
(B) the beneficial effects on those conditions generally expected from the medications;
(C) side effects and risks associated with the medications;
(D) commonly used examples of medications of the major type; and
(E) sources of detailed information concerning a particular medication.

(c) If the treating physician designates another person to provide the information under Subsection (a), then, not later than two working days after that person provides the information, excluding weekends and legal holidays, the physician shall meet with the patient and, if appropriate, the patient’s representative who provided consent for the administration of the medications under § 462.011, to review the information and answer any questions.
(d) The treating physician or the person designated by the physician shall also provide the information to the patient’s family on request, but only to the extent not otherwise prohibited by state or federal confidentiality laws.